Literature DB >> 6825384

A comparison of drug product information in four national compendia.

J L Alloza, L Lasagna.   

Abstract

Four widely used compendia of prescribing information have been received to examine the way in which some drug companies recommend uses for several anti-inflammatory products and describe the major dangers in their use. The Physician's Desk Reference (PDR) cites the greatest absolute number of indications for steroids with systemic action, as well as the greatest number of contraindications, warnings and precautions, and adverse effects. The total number of precautions appearing in the PDR is three times the mean for the other compendia, and the number of adverse effects is four times the mean of the others. Together, these other compendia contain 70.5% of the number of words in the PDR. The PDR contains statements that are strongly directive for the physician and that do not appear in the other compendia. Regulatory and social differences may at least partially explain these discrepancies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6825384     DOI: 10.1038/clpt.1983.32

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  4 in total

1.  Contraindication labelling changes in the United States and Germany.

Authors:  Edeltraut Garbe; Frank Andersohn
Journal:  Eur J Clin Pharmacol       Date:  2006-11-24       Impact factor: 2.953

2.  Discrepancies in listed adverse drug reactions in pharmaceutical product information supplied by the regulatory authorities in Denmark and the USA.

Authors:  Robert Eriksson; Lise Aagaard; Lars Juhl Jensen; Liza Borisova; Dorte Hørlück; Søren Brunak; Ebba Holme Hansen
Journal:  Pharmacol Res Perspect       Date:  2014-04-22

Review 3.  Development of new drugs in man: a review.

Authors:  I B Davies; I M Grind; A Pottage; P Turner
Journal:  J R Soc Med       Date:  1986-02       Impact factor: 5.344

Review 4.  Social pharmacology: expanding horizons.

Authors:  Rituparna Maiti; José Luis Alloza
Journal:  Indian J Pharmacol       Date:  2014 May-Jun       Impact factor: 1.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.